Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0432222 (SEM)
 47,337 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Although succimer (Chemet, meso-2,3-dimercaptosuccinic acid, DMSA) is considered to be a safe and effective chelating agent for the treatment of lead poisoning in humans, there is concern that it may increase the gastrointestinal (GI) absorption and retention of Pb from exposures suffered concurrent with treatment. This concern is justified because the availability of Pb-safe housing during outpatient treatment with oral succimer is limited. We used a juvenile nonhuman primate model of moderate childhood Pb intoxication and a sensitive double stable Pb isotope tracer methodology to determine whether oral succimer chelation affects the GI absorption and whole-body retention of Pb. Infant rhesus monkeys (n = 17) were exposed to Pb daily for 1 year postpartum to reach and maintain a target blood lead (BPb) level of 35-40 microg/dL. Animals were administered succimer (n = 9) or vehicle (n = 8) over two successive 19 day succimer treatment regimens beginning at 53 and 65 weeks of age. The present study was conducted over the second chelation regimen only. Animals received a single intravenous (iv) dose of stable (204)Pb tracer (5 microg, 24.5 nmol) followed by a single oral dose of stable (206)Pb tracer (72.6 microg, 352 nmol) immediately before chelation, in order to specifically evaluate GI Pb absorption and whole-body Pb retention with treatment. We collected complete urine and fecal samples over the first 5 days and whole blood over the first 8 days of treatment for analyses of stable Pb isotopes using magnetic sector inductively-coupled plasma mass spectrometry. Results indicate that succimer significantly reduced the GI absorption of Pb (vehicle, 64.9% +/- 5.5; succimer, 37.0% +/- 5.8; mean +/- SEM). Succimer also significantly increased the urinary excretion of endogenous Pb by approximately 4-fold over the vehicle treatment, while endogenous fecal Pb excretion was decreased by approximately 33%. Finally, although succimer reduced the whole-body retention of endogenous Pb by approximately 10% compared to vehicle, the majority (77%) of the administered internal dose of Pb tracer was retained in the body when assessed after 5 days of treatment. These data do not support the concern that succimer treatment increases GI Pb absorption.
 ...
PMID:Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys. 1144 16

Nickel ferrite nanoparticles were synthesized via a facile solvothermal approach. Oleylamine (OAm) was used in all synthetic procedures as a stabilizing agent and solvent. By varying the polarity of the solvents, hydrophobic NiFe2O4 nanoparticles coated with OAm of relatively similar sizes (9-11.7 nm) and in a range of magnetization values (32.0-53.5 emu g(-1)) were obtained. The as-prepared hydrophobic nanoparticles were characterized by XRD, TEM, SEM, TGA and VSM and converted to hydrophilic by two different approaches. The addition of a positively charged ligand (cetyltrimethyl ammonium bromide, CTAB) and the ligand exchange procedure (2,3-dimercaptosuccinic acid, DMSA) have been successfully applied. The aqueous suspensions of NiFe2O4@CTAB and NiFe2O4@DMSA showed good colloidal stability after a long period of time. The different surface modification affected both the NMR relaxometric measurements and the hyperthermia effects. In both techniques CTAB modification demonstrated higher r2 relaxivity (278.9 s(-1) mM(-1) in an NMR spectrometer at 11.7 T) and SAR values (423.4 W g(-1) at an applied AC field with a particle concentration of 0.5 mg mL(-1)). The results indicate that a coating with a larger molecule as CTAB under the same size, shape and magnetization of NiFe2O4 NPs gave rise to NMR relaxometric properties and heating efficacy.
...
PMID:Evaluation of nickel ferrite nanoparticles coated with oleylamine by NMR relaxation measurements and magnetic hyperthermia. 2441 65

This project aimed to develop and characterize a new nanoadsorbent for hemoperfusion. Fe3O4 nanoparticles synthesized by a facile solvothermal method were coated with SiO2 and further modified by DMSA. TEM, XRD, FTIR, XPS and SEM were performed before and after lead adsorption to reveal the general performance and adsorption mechanism. Rabbit lead poisoning models were established to study the adsorption rate; then, a pig hemoperfusion experiment was used for further validation. In addition, coagulation, liver, kidney and heart function, blood lipids, electrolytes and the immune inflammatory system were studied before and after hemoperfusion. The results indicated that the materials had a high adsorption rate and chemisorbed lead mainly in the plasma. No obvious coagulation-fibrinolysis, organ toxicity, electrolyte disturbances, inflammatory reactions or immunosuppression was observed. The excellent blood compatibility and high biosafety of this material demonstrate its potential as a new type of hemoperfusion adsorbent.
 ...
PMID:Lead adsorption, anticoagulation and in vivo toxicity studies on the new magnetic nanomaterial Fe3O4@SiO2@DMSA as a hemoperfusion adsorbent. 2811 50